A detailed history of Guidance Capital, Inc transactions in Boston Scientific Corp stock. As of the latest transaction made, Guidance Capital, Inc holds 5,794 shares of BSX stock, worth $578,820. This represents 0.17% of its overall portfolio holdings.

Number of Shares
5,794
Previous 3,779 53.32%
Holding current value
$578,820
Previous $397 Million 54.02%
% of portfolio
0.17%
Previous 0.12%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 07, 2025

BUY
$89.7 - $107.41 $180,745 - $216,431
2,015 Added 53.32%
5,794 $611 Million
Q1 2025

May 05, 2025

BUY
$89.38 - $106.18 $337,767 - $401,254
3,779 New
3,779 $397 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $143B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Guidance Capital, Inc Portfolio

Follow Guidance Capital, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guidance Capital, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Guidance Capital, Inc with notifications on news.